Evaxion A (EVAX) Return on Invested Capital (2021 - 2026)
Evaxion A (EVAX) reported Return on Invested Capital of 0.01% for Q1 2026, up 3.0% on a YoY basis from 0.01% in Q1 2025, and down 56.71% quarter-over-quarter from 0.01% in Q4 2025.
Evaxion A (EVAX) Return on Invested Capital (2021 - 2026) Analysis & Trends
Evaxion A has reported Return on Invested Capital for 6 years, with the latest figure at 0.01% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital rose 3.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (up 3.0% YoY), and the FY2025 full-year result was 0.01%, up 2.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.01%, down from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q4 2025, with the low at 1.42% in Q2 2024.
- Historically, Return on Invested Capital has averaged 0.24% across 5 years, with a median of 0.11% in 2024.
- Annual changes were most pronounced in 2024 — Return on Invested Capital slumped 135 bps — and 2025, when it jumped 82 bps.
- Evaxion A's Return on Invested Capital stood at 0.03% in 2022, then slumped by 300 bps to 0.11% in 2023, then soared by 57 bps to 0.05% in 2024, then soared by 86 bps to 0.01% in 2025, then sank by 57 bps to 0.01% in 2026.
- The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.01% (Q4 2025), and 0.32% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.32% |
| Jun 30, 2025 | -0.59% |
| Mar 31, 2025 | -0.04% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -1.01% |
| Jun 30, 2024 | -1.42% |
| Mar 31, 2024 | -0.11% |
| Dec 31, 2023 | -0.11% |
| Sep 30, 2023 | -0.11% |
| Jun 30, 2023 | -0.06% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.12% |
| Jun 30, 2022 | -0.12% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |